These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 15273654

  • 1. Local injection of receptor tyrosine kinase inhibitor MAE 87 reduces retinal neovascularization in mice.
    Unsoeld AS, Junker B, Mazitschek R, Martin G, Hansen LL, Giannis A, Agostini HT.
    Mol Vis; 2004 Jul 15; 10():468-75. PubMed ID: 15273654
    [Abstract] [Full Text] [Related]

  • 2. Intravitreal injection of the heparin analog 5-amino-2-naphthalenesulfonate reduces retinal neovascularization in mice.
    Lange C, Ehlken C, Martin G, Konzok K, Moscoso Del Prado J, Hansen LL, Agostini HT.
    Exp Eye Res; 2007 Sep 15; 85(3):323-7. PubMed ID: 17662276
    [Abstract] [Full Text] [Related]

  • 3. Soluble forms of EphrinB2 and EphB4 reduce retinal neovascularization in a model of proliferative retinopathy.
    Zamora DO, Davies MH, Planck SR, Rosenbaum JT, Powers MR.
    Invest Ophthalmol Vis Sci; 2005 Jun 15; 46(6):2175-82. PubMed ID: 15914639
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Herbimycin A inhibits angiogenic activity in endothelial cells and reduces neovascularization in a rat model of retinopathy of prematurity.
    McCollum GW, Rajaratnam VS, Bullard LE, Yang R, Penn JS.
    Exp Eye Res; 2004 May 15; 78(5):987-95. PubMed ID: 15051479
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effects of tetrathiomolybdate in a mouse model of retinal neovascularization.
    Elner SG, Elner VM, Yoshida A, Dick RD, Brewer GJ.
    Invest Ophthalmol Vis Sci; 2005 Jan 15; 46(1):299-303. PubMed ID: 15623788
    [Abstract] [Full Text] [Related]

  • 10. Intravitreal injection of specific receptor tyrosine kinase inhibitor PTK787/ZK222 584 improves ischemia-induced retinopathy in mice.
    Maier P, Unsoeld AS, Junker B, Martin G, Drevs J, Hansen LL, Agostini HT.
    Graefes Arch Clin Exp Ophthalmol; 2005 Jun 15; 243(6):593-600. PubMed ID: 15650859
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Geldanamycin treatment reduces neovascularization in a mouse model of retinopathy of prematurity.
    Kociok N, Krohne TU, Poulaki V, Joussen AM.
    Graefes Arch Clin Exp Ophthalmol; 2007 Feb 15; 245(2):258-66. PubMed ID: 16741710
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of retinal and choroidal neovascularization by a novel KDR kinase inhibitor.
    Kinose F, Roscilli G, Lamartina S, Anderson KD, Bonelli F, Spence SG, Ciliberto G, Vogt TF, Holder DJ, Toniatti C, Thut CJ.
    Mol Vis; 2005 May 27; 11():366-73. PubMed ID: 15951738
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Altered retinal neovascularization in TNF receptor-deficient mice.
    Ilg RC, Davies MH, Powers MR.
    Curr Eye Res; 2005 Nov 27; 30(11):1003-13. PubMed ID: 16282134
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. CAI is a potent inhibitor of neovascularization and imparts neuroprotection in a mouse model of ischemic retinopathy.
    Franklin AJ, Jetton TL, Kuchemann CL, Russell SR, Kohn EC.
    Invest Ophthalmol Vis Sci; 2004 Oct 27; 45(10):3756-66. PubMed ID: 15452087
    [Abstract] [Full Text] [Related]

  • 19. Effects of sustained hyperoxia on revascularization in experimental retinopathy of prematurity.
    Gu X, Samuel S, El-Shabrawey M, Caldwell RB, Bartoli M, Marcus DM, Brooks SE.
    Invest Ophthalmol Vis Sci; 2002 Feb 27; 43(2):496-502. PubMed ID: 11818396
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of oxygen-induced retinopathy in RTP801-deficient mice.
    Brafman A, Mett I, Shafir M, Gottlieb H, Damari G, Gozlan-Kelner S, Vishnevskia-Dai V, Skaliter R, Einat P, Faerman A, Feinstein E, Shoshani T.
    Invest Ophthalmol Vis Sci; 2004 Oct 27; 45(10):3796-805. PubMed ID: 15452091
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.